Novavax COVID-19 Vaccine

Novavax COVID-19 vaccine

The Novavax vaccine is the fourth one to be authorized in the United States for the prevention of COVID-19.

Anyone 12 or older can get the Novavax vaccine. It’s a two-dose primary series, with the second shot given three to eight weeks after the first. 

If you believe you are sick, please wear a face mask going to the pharmacy

1. Download, Print, and fill Covid-19 Vaccine Form
2. Please bring a copy of your appointment confirmation or save a screenshot on your phone
3.  Bring a copy of your medical/supplemental insurance card to the appointment.
4.  The address is welltopia pharmacy, 136 N MAIN ST, Thiensville, WI 53092. park in front of the pharmacy or on Main Street and go through the pharmacy door to the main entrance then go to the pharmacy counter.

PLEASE BOOK THE SECOND APPOINTMENT AFTER 21 DAYS FROM THE FIRST SHOT  APPOINTMENT

This is for the First and Second shots only

Covid Booster shot booking from here

How is Novavax different than the other COVID-19 vaccines in the U.S.?

Though COVID vaccines may utilize different delivery mechanisms, the end result is the same: cells in the body recognize that a spike protein (the spikes you see sticking out of the coronavirus in pictures) doesn’t belong, and the immune system reacts by activating immune cells and producing antibodies to attack the real virus if you get exposed.

But, unlike the other vaccines, Novavax directly injects a version of the spike protein, along with another ingredient that also stimulates the immune system, into the body, leading to the production of antibodies and T-cells. (It injects a version of the spike protein that has been formulated in a laboratory as a nanoparticulate that does not have genetic material inside and cannot cause disease.)

“I often tell people, imagine an eggshell without an egg in it. That’s what it is,” Dr. Wilson says.

The Novavax vaccine is a traditional one compared to the other vaccines. Its technology has been used before in vaccines to prevent such conditions as shingles, human papillomavirus, and DTaP (diphtheria, tetanus, and pertussis), among others.

Has the Novavax vaccine been authorized outside of the U.S.?

Yes. The Novavax coronavirus vaccine (brand names: Nuvaxovid and Covovax) is already being used to prevent the coronavirus in 40 other countries, including Canada. 

Novavax is based in Maryland, and the vaccine was developed in the U.S. in 2020 with support from the federal government program Operation Warp Speed, but it’s progress was slowed by manufacturing difficulties. Finally, in November 2021, countries around the world, starting with Indonesia and the Philippines, later followed by the United Kingdom, began granting authorizations for the vaccine. 

Novavax applied to the FDA for authorization in January of this year.

Who can get the Novavax vaccine?